- A risk prediction model for delayed graft function in the current era of deceased donor renal transplantationW D Irish
Biostatistics and Health Outcomes Research, CTI Clinical Trial and Consulting Services, Cincinnati, OH, USA
Am J Transplant 10:2279-86. 2010..This tool is useful for predicting DGF and long-term outcomes at the time of transplant...
- Cyclosporine versus tacrolimus treated liver transplant recipients with chronic hepatitis C: outcomes analysis of the UNOS/OPTN databaseW D Irish
Health Outcomes Research and Biostatistics, CTI Clinical Trial and Consulting Services, Raleigh, NC, USA
Am J Transplant 11:1676-85. 2011..35, respectively] and biopsy-confirmed AR (HR = 2.03; 95% CI = 1.54-2.67) compared to TAC treated patients. These results provide evidence to reconsider the targeted administration of CSA-ME to HCV-infected liver transplant recipients...